Avivagen Inc., a life sciences innovation company with a series of patent protected products that support and optimize animal health, announced the relaunch of its Vivamune Health Chew supplement for dogs in the U.S.
“My focus has always been on products that really work for dogs,” dog behaviorist expert Cesar Millan said. “I have a team of veterinarians that I work with to help evaluate products. Everyone was impressed with Vivamune Health Chews. Vivamune has shown remarkable results with our pack already and I’m excited to help this innovative Canadian company share its product with more people.”
At the heart of Vivamune is an active substance, called OxC-beta compound, Avivagen’s proprietary formulation of fully oxidized β-carotene. OxC-beta benefits animal health through a novel combination of effects upon the animal’s own immune system.
Vivamune provides dogs with a unique combination of health benefits, including support for skin, joint and gut health. Vivamune soothes skin-related issues due to seasonal allergies and maintains overall skin quality; it eases stiffness and promotes healthy hip and joint function.
This once-a-day chew simplifies a dog’s daily supplement routine by providing a pet with comprehensive support against the most common canine health problems—skin and joint issues —while also providing proactive, protective immune function abilities.
“It’s vibrant health made simple. That’s it!,” Millan said.
Combining Vivamune’s capabilities with an enthusiastic endorsement from Millan, who is featured on the new packaging, as well as a multi-faceted marketing and rebranding campaign, Avivagen believes that Vivamune is positioned to increase both brand awareness and market share.
Avivagen is currently seeking distribution partnerships, as well as online and in-store retail opportunities. The product is available only in the U.S. and is made in U.S. facilities.